While newer, faster technologies are in development, it will still be some time before they’re in regular use.
- Associate Professor in Biomedical Technology, University of Southampton
Chronic weaknesses in our global vaccine manufacturing and distribution systems may broadly be to blame.
Both drugs significantly reduce the chance of people vulnerable to COVID being hospitalised – but they stop the virus in different ways.
Scientists are working hard to develop reliable tests that can detect anti-virus antibodies from past infection.
Contact Alexander for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Website
- Article Feed
- ORCID
- Joined
